Bristol-Myers Squibb Co at JPMorgan Healthcare Conference Transcript
Good morning, everybody. I'm Chris Schott at JPMorgan. It's great to see everybody back in person again this year for a second year in a row. It's my pleasure this morning, though, to be introducing Bristol-Myers to again kick off the JPMorgan Healthcare Conference.
From the company, we have Chris Boerner who recently stepped into the CEO seat at Bristol, and looking forward to the conversation here, given all the updates and deal activity we've seen from the company recently.
So with that, Chris, Happy New Year. Thanks for joining us and look forward to the presentation.
Thank you, Chris. So good morning, everyone. It is great to be kicking off the 2024 JPMorgan conference.
As Chris referenced, I have been in the CEO role now just over 2 months, and I am incredibly proud and excited to be taking over the leadership of this company with its over 150-year history of bringing
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |